Form 4: NeuroOne Medical Technologies Director Disposes of Shares for Tax Obligations
Insider Transaction Report
Mark Christianson, Business Development Director at NeuroOne Medical Technologies Corp, disposed of 253 shares of common stock to satisfy tax withholding obligations.
Summary
- Mark Christianson, the Business Development Director of NeuroOne Medical Technologies Corp (NMTC), reported a disposition of common stock.
- On June 30, 2025, Christianson disposed of 253 shares of common stock at a price of $0.678 per share.
- This transaction was coded as 'F', indicating a disposition to the issuer to satisfy tax withholding obligations related to the vesting of restricted stock or similar equity awards.
- Following this transaction, Mark Christianson beneficially owns 261,238 shares of NeuroOne Medical Technologies Corp common stock directly.
Sentiment
Score: 5
Explanation: The transaction is administrative (disposition for tax withholding) and does not reflect a discretionary buy or sell decision, thus having a neutral impact on sentiment regarding the company's prospects.
Future Outlook
NA
Industry Context
This Form 4 filing is a routine disclosure of an insider stock transaction, common across all publicly traded companies, and does not provide specific insights into broader industry trends or competitive landscape beyond the company's internal equity compensation practices.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Power of Attorney Establishment | Mark Christianson granted a Power of Attorney to Ronald McClurg, Emily Johns, Phillip Torrence, and Stephanie Swan, authorizing them to prepare, execute, submit, and file SEC forms (including Forms 3, 4, and 5) on his behalf. This ensures compliance with Section 16 reporting requirements. | 2025-06-18 | Streamlines the process for insider SEC filings, ensuring timely and accurate compliance with reporting obligations. |
Related Party Transactions
- Disposition of 253 shares of common stock by Mark Christianson, a Business Development Director, to NeuroOne Medical Technologies Corp to satisfy tax withholding obligations, which is an administrative transaction between an insider and the company.
Stakeholder Impact
- Shareholders: Minimal direct impact as this is a small, administrative disposition of shares for tax purposes, not a discretionary sale indicating a change in confidence. The number of shares is negligible relative to the total outstanding shares.
- Employees: No direct impact indicated beyond the reporting person's equity compensation structure.
Key Dates
| Date | Description |
|---|---|
| 2025-06-18 | Date Mark Christianson executed the Power of Attorney authorizing others to file SEC forms on his behalf. |
| 2025-06-30 | Date of the reported transaction where 253 shares were disposed of. |
| 2025-07-02 | Date the Form 4 was signed by Emily Johns, by Power of Attorney. |
Keywords
NeuroOne Medical Technologies, NMTC, Insider Trading, Form 4, Stock Disposition, Tax Withholding, Mark Christianson, Business Development Director
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.